source
- STAT+: The China question is tearing biotech apartChina's ascent is forcing U.S. biotech companies and investors to pick a side: Is it an ally or an existential threat?STAT · 3mo ago↗ source
- Opinion: How to restore credibility to the CDC’s vaccine advisory committeeJesse Goodman, former director of CBER and former FDA chief scientist, calls for five critical changes to restore trust in the Advisory Committee on Immunization Practices.STAT · 3mo ago↗ source
- STAT+: U.K. advocacy groups threaten court action over a key provision in the pharma trade deal with the U.S.A pair of advocacy groups is threatening legal action unless the U.K. government revokes regulations at the heart of a new pharma trade agreement with the U.S.STAT